Description
CVT-313 is a potent and selective inhibitor of cyclin-dependent kinase 2 (CDK2).
Product Unit Size | Cost | Quantity | Stock |
---|
CVT-313 is a potent and selective inhibitor of cyclin-dependent kinase 2 (CDK2).
Cas No. | 199986-75-9 |
---|---|
Purity | ≥98% |
Formula | C22H28N6O3 |
Formula Wt. | 400.48 |
IUPAC Name | 2,2'-({9-Isopropyl-6-[(4-methoxybenzyl)amino]-9H-purin-2-yl}imino)diethanol |
Synonym | CVT313; Cdk2 Inhibitor III; Cyclin-dependent kinase 2 Inhibitor III |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Brooks E., Gray N., et al. CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem. 272(46):29207-11 (1997). PMID: 9360999.
Faber A., Chiles T. Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas. Cell Cycle. 6(23):2982-9 (2007). PMID: 18156799.
Viral RNA polymerase inhibitor.
Non-selective HDAC inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
β-adrenergic antagonist, Kv1.4 and K2P2 K+ cha...
Resveratrol prodrug; potential SIRT1 activator....
Imidazoquinazoline; PDE3 inhibitor.
Macrocyclic lactone avermectin; GABA antagonist...
Benzyl taxol analog; potential microtubule depo...
Prolyl hydroxylase inhibitor.
β2-adrenergic agonist.
Pyrimidine, glucose analog, used to induce diab...
FAAH inhibitor.
Organosulfur found in cruciferous vegetables; a...
PRMT5 inhibitor
Tretraeptide, binds cell surface integrins.
α4β2 nAChR desensitizer, delayed-rectifier vo...
p53 inhibitor
Walrycin response regulator inhibitor.
Inhibitor of EGFR, HER2, and HER3.
D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...